Title: Neupogen (trademark) (filgrastim) advances in oncology
Subjects: Therapeutic use, Immune response, Regulation, Filgrastim, Oncology, Recombinant Proteins, Pharmacology, Colony-Stimulating Factors, Neutrophils, Drug effects, Drug Therapy, Adverse effects, Drug-Related Side Effects and Adverse Reactions